Pneumonia III: Complications and Assessment
Viral Recombination
Pneumonia I: Introduction
Pneumonia IV: Management
Vaccinations
Viral Mutations
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Shanshan Wang1, Bin Li1, Qiong Chen1
1Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, Research Units of Innovative Vaccine Quality Evaluation and Standardization, Chinese Academy of Medical Sciences, National Institutes of Food and Drug Control, Beijing, People's Republic of China.
侵入性肺炎球菌病 (IPD) 在中国构成重大威胁. 这份审查审查了IPD,可用的疫苗,如PPV23和PCV13,以及更好的控制和监测策略.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: